VIEWS: 29 PAGES: 1 CATEGORY: Press Releases POSTED ON: 9/4/2010
NEW YORK--(EON: Enhanced Online News)--The Rosen Law Firm today announced that it has commenced an investigation into allegations that AspenBio Pharma, Inc. (“AspenBio” or the “Company”) (Nasdaq: APPY - News) violated the federal securities laws by issuing false and misleading statements to investors about its product candidate AppyScore. Since as early February 15, 2006, AspenBio has been touting AppyScore as an effective test to diagnose appendicitis. On June 7, 2010, the Company disclosed the a style='f
"Investor Notice: The Rosen Law Firm Announces Investigation of Shareholder Securities Claims Against AspenBio Pharma, Inc. --- APPY"